PMID- 25865370 OWN - NLM STAT- MEDLINE DCOM- 20160517 LR - 20150729 IS - 1600-0625 (Electronic) IS - 0906-6705 (Linking) VI - 24 IP - 8 DP - 2015 Aug TI - Decorin-expressing adenovirus decreases collagen synthesis and upregulates MMP expression in keloid fibroblasts and keloid spheroids. PG - 591-7 LID - 10.1111/exd.12719 [doi] AB - Decorin is a natural transforming growth factor-beta1 (TGF-beta1) antagonist. Reduced decorin synthesis is associated with dermal scarring, and increased decorin expression appears to reduce scar tissue formation. To investigate the therapeutic potential of decorin for keloids, human dermal fibroblasts (HDFs) and keloid-derived fibroblasts (KFs) were transduced with decorin-expressing adenovirus (dE1-RGD/GFP/DCN), and we examined the therapeutic potential of decorin-expressing Ad for treating pathologic skin fibrosis. Decorin expression was examined by immunofluorescence assay on keloid tissues. HDFs and KFs were transduced with dE1-RGD/GFP/DCN or control virus, and protein levels of decorin, epidermal growth factor receptor (EGFR) and secreted TGF-beta1 were assessed by Western blotting and ELISA. And type I and III collagen, and matrix metalloproteinase-1 (MMP-1) and matrix metalloproteinase-3 (MMP-3) mRNA levels were measured by real-time RT-PCR. Additionally, we immunohistochemically investigated the expression levels of the major extracellular matrix (ECM) proteins in keloid spheroids transduced with dE1-RGD/GFP/DCN. Lower decorin expression was observed in the keloid region compared to adjacent normal tissues. After treatment with dE1-RGD/GFP/DCN, secreted TGF-beta1 and EGFR protein expressions were decreased in TGF-beta1-treated HDFs and KFs. Also, type I and III collagen mRNA levels were decreased, and the expression of MMP-1 and MMP-3 mRNA was strongly upregulated. In addition, the expression of type I and III collagen, fibronectin and elastin was significantly reduced in dE1-RGD/GFP/DCN-transduced keloid spheroids. These results support the utility of decorin-expressing adenovirus to reduce collagen synthesis in KFs and keloid spheroid, which may be highly beneficial in treating keloids. CI - (c) 2015 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd. FAU - Lee, Won Jai AU - Lee WJ AD - Department of Plastic and Reconstructive Surgery, College of Medicine, Institute for Human Tissue Restoration, Yonsei University, Seoul, Korea. FAU - Ahn, Hyo Min AU - Ahn HM AD - Department of Bioengineering, College of Engineering, Hanyang University, Seoul, Korea. FAU - Roh, Hyun AU - Roh H AD - Department of Plastic and Reconstructive Surgery, College of Medicine, Institute for Human Tissue Restoration, Yonsei University, Seoul, Korea. FAU - Na, Youjin AU - Na Y AD - Department of Bioengineering, College of Engineering, Hanyang University, Seoul, Korea. FAU - Choi, Il-Kyu AU - Choi IK AD - Department of Bioengineering, College of Engineering, Hanyang University, Seoul, Korea. FAU - Lee, Ju Hee AU - Lee JH AD - Department of Dermatology and Cutaneous Biology Research Institute, College of Medicine, Yonsei University, Seoul, Korea. FAU - Kim, Yong Oock AU - Kim YO AD - Department of Plastic and Reconstructive Surgery, College of Medicine, Institute for Human Tissue Restoration, Yonsei University, Seoul, Korea. FAU - Lew, Dae Hyun AU - Lew DH AD - Department of Plastic and Reconstructive Surgery, College of Medicine, Institute for Human Tissue Restoration, Yonsei University, Seoul, Korea. FAU - Yun, Chae-Ok AU - Yun CO AD - Department of Bioengineering, College of Engineering, Hanyang University, Seoul, Korea. LA - eng GR - R01 R0CA177932/CA/NCI NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural PT - Research Support, Non-U.S. Gov't DEP - 20150508 PL - Denmark TA - Exp Dermatol JT - Experimental dermatology JID - 9301549 RN - 0 (Collagen Type I) RN - 0 (Collagen Type III) RN - 0 (DCN protein, human) RN - 0 (Decorin) RN - 0 (Extracellular Matrix Proteins) RN - 0 (RNA, Messenger) RN - EC 3.4.24.17 (MMP3 protein, human) RN - EC 3.4.24.17 (Matrix Metalloproteinase 3) RN - EC 3.4.24.7 (MMP1 protein, human) RN - EC 3.4.24.7 (Matrix Metalloproteinase 1) SB - IM MH - Adenoviridae/*genetics MH - Cells, Cultured MH - Collagen Type I/biosynthesis/genetics MH - Collagen Type III/biosynthesis/genetics MH - Decorin/genetics/*therapeutic use MH - Extracellular Matrix Proteins/*biosynthesis/genetics MH - Fibroblasts/*metabolism/pathology MH - *Gene Expression Regulation MH - *Genetic Therapy MH - Genetic Vectors/genetics/*pharmacology MH - Humans MH - Keloid/metabolism/*pathology MH - Matrix Metalloproteinase 1/*biosynthesis/genetics MH - Matrix Metalloproteinase 3/*biosynthesis/genetics MH - RNA, Messenger/biosynthesis/genetics MH - Real-Time Polymerase Chain Reaction MH - Skin/pathology MH - Spheroids, Cellular OTO - NOTNLM OT - MMP OT - collagen OT - decorin-expressing adenovirus OT - gene therapy OT - keloid OT - keloid spheroid EDAT- 2015/04/14 06:00 MHDA- 2016/05/18 06:00 CRDT- 2015/04/14 06:00 PHST- 2015/04/08 00:00 [accepted] PHST- 2015/04/14 06:00 [entrez] PHST- 2015/04/14 06:00 [pubmed] PHST- 2016/05/18 06:00 [medline] AID - 10.1111/exd.12719 [doi] PST - ppublish SO - Exp Dermatol. 2015 Aug;24(8):591-7. doi: 10.1111/exd.12719. Epub 2015 May 8.